Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Capital One Financial upgraded shares of Kodiak Sciences (NASDAQ:KOD – Free Report) from an equal weight rating to an overweight rating in a research report released on Friday, MarketBeat reports. The firm currently has $12.00 price objective on the stock, up from their prior price objective of $7.00. A number of other brokerages have also […]
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 31st, there was short interest totalling 3,350,000 shares, a drop of 14.3% from the October 15th total of 3,910,000 shares. Approximately 6.8% of the shares of the stock are short sold. Based […]
A phase 3 trial showed that tarcocimab, a biopolymer with a vascular growth factor antibody, improved vision and anatomical markers in patients with early stage diabetic retinopathy.
Some degree of improvement in disease status in 70% of patients treated with tarcocimab